Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Genetic diversity, inbreeding and cancer.

Ujvari B, Klaassen M, Raven N, Russell T, Vittecoq M, Hamede R, Thomas F, Madsen T.

Proc Biol Sci. 2018 Mar 28;285(1875). pii: 20172589. doi: 10.1098/rspb.2017.2589. Review.

2.

Cancer Is Not (Only) a Senescence Problem.

Thomas F, Vavre F, Tissot T, Vittecoq M, Giraudeau M, Bernex F, Misse D, Renaud F, Raven N, Beckmann C, Hamede R, Biro PA, Ujvari B.

Trends Cancer. 2018 Mar;4(3):169-172. doi: 10.1016/j.trecan.2018.01.002.

PMID:
29506667
3.

Evolved Dependence in Response to Cancer.

Thomas F, Kareva I, Raven N, Hamede R, Pujol P, Roche B, Ujvari B.

Trends Ecol Evol. 2018 Apr;33(4):269-276. doi: 10.1016/j.tree.2018.01.012. Epub 2018 Feb 20. Review.

PMID:
29475741
4.

Oncogenesis as a Selective Force: Adaptive Evolution in the Face of a Transmissible Cancer.

Russell T, Madsen T, Thomas F, Raven N, Hamede R, Ujvari B.

Bioessays. 2018 Mar;40(3). doi: 10.1002/bies.201700146. Epub 2018 Feb 15. Review.

PMID:
29446482
5.

Purifying selection and concerted evolution of RNA-sensing toll-like receptors in migratory waders.

Raven N, Lisovski S, Klaassen M, Lo N, Madsen T, Ho SYW, Ujvari B.

Infect Genet Evol. 2017 Sep;53:135-145. doi: 10.1016/j.meegid.2017.05.012. Epub 2017 May 18.

PMID:
28528860
6.

Plant Cell-Based Recombinant Antibody Manufacturing with a 200 L Orbitally Shaken Disposable Bioreactor.

Raven N, Schillberg S, Rasche S.

Methods Mol Biol. 2016;1385:161-72. doi: 10.1007/978-1-4939-3289-4_12.

PMID:
26614289
7.

High-yield production of a human monoclonal IgG by rhizosecretion in hydroponic tobacco cultures.

Madeira LM, Szeto TH, Henquet M, Raven N, Runions J, Huddleston J, Garrard I, Drake PM, Ma JK.

Plant Biotechnol J. 2016 Feb;14(2):615-24. doi: 10.1111/pbi.12407. Epub 2015 Jun 3.

8.

In situ cell retention of a CHO culture by a reverse-flow diafiltration membrane bioreactor.

Meier K, Djeljadini S, Regestein L, Büchs J, Carstensen F, Wessling M, Holland T, Raven N.

Biotechnol Prog. 2014 Nov-Dec;30(6):1348-55. doi: 10.1002/btpr.1988. Epub 2014 Sep 18.

PMID:
25202924
9.

Scaled-up manufacturing of recombinant antibodies produced by plant cells in a 200-L orbitally-shaken disposable bioreactor.

Raven N, Rasche S, Kuehn C, Anderlei T, Klöckner W, Schuster F, Henquet M, Bosch D, Büchs J, Fischer R, Schillberg S.

Biotechnol Bioeng. 2015 Feb;112(2):308-21. doi: 10.1002/bit.25352. Epub 2014 Oct 13.

PMID:
25117428
10.

Correlation between mass transfer coefficient kLa and relevant operating parameters in cylindrical disposable shaken bioreactors on a bench-to-pilot scale.

Klöckner W, Gacem R, Anderlei T, Raven N, Schillberg S, Lattermann C, Büchs J.

J Biol Eng. 2013 Dec 2;7(1):28. doi: 10.1186/1754-1611-7-28.

11.

Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody.

Häkkinen ST, Raven N, Henquet M, Laukkanen ML, Anderlei T, Pitkänen JP, Twyman RM, Bosch D, Oksman-Caldentey KM, Schillberg S, Ritala A.

Biotechnol Bioeng. 2014 Feb;111(2):336-46. doi: 10.1002/bit.25113. Epub 2013 Sep 24.

PMID:
24030771
12.

Optimization of BY-2 cell suspension culture medium for the production of a human antibody using a combination of fractional factorial designs and the response surface method.

Vasilev N, Grömping U, Lipperts A, Raven N, Fischer R, Schillberg S.

Plant Biotechnol J. 2013 Sep;11(7):867-74. doi: 10.1111/pbi.12079. Epub 2013 May 30.

13.

Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures.

Schillberg S, Raven N, Fischer R, Twyman RM, Schiermeyer A.

Curr Pharm Des. 2013;19(31):5531-42. Review.

PMID:
23394569
14.

Bioassay studies support the potential for iatrogenic transmission of variant Creutzfeldt Jakob Disease through dental procedures.

Kirby E, Dickinson J, Vassey M, Dennis M, Cornwall M, McLeod N, Smith A, Marsh PD, Walker JT, Sutton JM, Raven ND.

PLoS One. 2012;7(11):e49850. doi: 10.1371/journal.pone.0049850. Epub 2012 Nov 30.

15.

Organic solutes in the deepest phylogenetic branches of the Bacteria: identification of α(1-6)glucosyl-α(1-2)glucosylglycerate in Persephonella marina.

Lamosa P, Rodrigues MV, Gonçalves LG, Carr J, Ventura R, Maycock C, Raven ND, Santos H.

Extremophiles. 2013 Jan;17(1):137-46. doi: 10.1007/s00792-012-0500-x. Epub 2012 Nov 24.

PMID:
23179593
16.

Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting.

Kirchhoff J, Raven N, Boes A, Roberts JL, Russell S, Treffenfeldt W, Fischer R, Schinkel H, Schiermeyer A, Schillberg S.

Plant Biotechnol J. 2012 Oct;10(8):936-44. doi: 10.1111/j.1467-7652.2012.00722.x. Epub 2012 Jul 3.

17.

Readily achievable.

Sutton JM, Walker JT, Raven ND, Marsh P, Smith A, Perrett D.

Br Dent J. 2011 Aug 26;211(4):152. doi: 10.1038/sj.bdj.2011.687. No abstract available.

PMID:
21869775
18.

A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods.

Vassey M, Budge C, Poolman T, Jones P, Perrett D, Nayuni N, Bennett P, Groves P, Smith A, Fulford M, Marsh PD, Walker JT, Sutton JM, Raven ND.

Br Dent J. 2011 May 14;210(9):E14. doi: 10.1038/sj.bdj.2011.144.

PMID:
21372833
19.

Quantitative measurement of the efficacy of protein removal by cleaning formulations; comparative evaluation of prion-directed cleaning chemistries.

Ungurs M, Hesp JR, Poolman T, McLuckie G, O'Brien S, Murdoch H, Wells P, Raven ND, Walker JT, Sutton JM.

J Hosp Infect. 2010 Feb;74(2):144-51. doi: 10.1016/j.jhin.2009.07.023. Epub 2009 Oct 14.

PMID:
19833409
20.

Thermostable adenylate kinase technology: a new process indicator and its use as a validation tool for the reprocessing of surgical instruments.

Hesp JR, Poolman TM, Budge C, Batten L, Alexander F, McLuckie G, O'Brien S, Wells P, Raven ND, Sutton JM.

J Hosp Infect. 2010 Feb;74(2):137-43. doi: 10.1016/j.jhin.2009.07.019. Epub 2009 Sep 25.

PMID:
19782433
21.

Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco.

Bortesi L, Rossato M, Schuster F, Raven N, Stadlmann J, Avesani L, Falorni A, Bazzoni F, Bock R, Schillberg S, Pezzotti M.

BMC Biotechnol. 2009 Mar 19;9:22. doi: 10.1186/1472-6750-9-22.

22.

Decontamination of prion protein (BSE301V) using a genetically engineered protease.

Dickinson J, Murdoch H, Dennis MJ, Hall GA, Bott R, Crabb WD, Penet C, Sutton JM, Raven ND.

J Hosp Infect. 2009 May;72(1):65-70. doi: 10.1016/j.jhin.2008.12.007. Epub 2009 Feb 6.

PMID:
19201054
23.

Implications for Creutzfeldt-Jakob disease (CJD) in dentistry: a review of current knowledge.

Walker JT, Dickinson J, Sutton JM, Marsh PD, Raven ND.

J Dent Res. 2008 Jun;87(6):511-9. Review.

PMID:
18502958
24.

Cleanability of dental instruments--implications of residual protein and risks from Creutzfeldt-Jakob disease.

Walker JT, Dickinson J, Sutton JM, Raven ND, Marsh PD.

Br Dent J. 2007 Oct 13;203(7):395-401.

PMID:
17934424
25.

A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.

Hesp JR, Raven ND, Sutton JM.

Biochem Biophys Res Commun. 2007 Oct 26;362(3):695-9. Epub 2007 Aug 17.

PMID:
17761148
26.

Occurrence of 1-glyceryl-1-myo-inosityl phosphate in hyperthermophiles.

Lamosa P, Gonçalves LG, Rodrigues MV, Martins LO, Raven ND, Santos H.

Appl Environ Microbiol. 2006 Sep;72(9):6169-73.

27.

Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?

Sutton JM, Dickinson J, Walker JT, Raven ND.

Clin Infect Dis. 2006 Sep 15;43(6):757-64. Epub 2006 Aug 11. Review.

PMID:
16912952
28.

Surface decontamination of surgical instruments: an ongoing dilemma.

Murdoch H, Taylor D, Dickinson J, Walker JT, Perrett D, Raven ND, Sutton JM.

J Hosp Infect. 2006 Aug;63(4):432-8. Epub 2006 Jun 8.

PMID:
16759745
29.

Stabilization of Enzymes against Thermal Stress and Freeze-Drying by Mannosylglycerate.

Ramos A, Raven N, Sharp RJ, Bartolucci S, Rossi M, Cannio R, Lebbink J, Van Der Oost J, De Vos WM, Santos H.

Appl Environ Microbiol. 1997 Oct;63(10):4020-5.

30.

Proteolytic inactivation of the bovine spongiform encephalopathy agent.

McLeod AH, Murdoch H, Dickinson J, Dennis MJ, Hall GA, Buswell CM, Carr J, Taylor DM, Sutton JM, Raven ND.

Biochem Biophys Res Commun. 2004 May 14;317(4):1165-70. Erratum in: Biochem Biophys Res Commun. 2004 Sep 3;321(4):1069.

PMID:
15094392
31.

Comparative study of the thermostabilizing properties of mannosylglycerate and other compatible solutes on model enzymes.

Borges N, Ramos A, Raven ND, Sharp RJ, Santos H.

Extremophiles. 2002 Jun;6(3):209-16. Epub 2002 Feb 27.

PMID:
12072956
32.

Crystallization and preliminary X-ray analysis of RecG, a replication-fork reversal helicase from Thermotoga maritima complexed with a three-way DNA junction.

Singleton MR, Scaife S, Raven ND, Wigley DB.

Acta Crystallogr D Biol Crystallogr. 2001 Nov;57(Pt 11):1695-6. Epub 2001 Oct 25.

PMID:
11679748
33.

Analysis of single-chain antibody production in Pichia pastoris using on-line methanol control in fed-batch and mixed-feed fermentations.

Hellwig S, Emde F, Raven NP, Henke M, van Der Logt P, Fischer R.

Biotechnol Bioeng. 2001 Aug 20;74(4):344-52.

PMID:
11410859
34.

A microbiological survey of Montserrat Island hydrothermal biotopes.

Atkinson T, Cairns S, Cowan DA, Danson MJ, Hough DW, Johnson DB, Norris PR, Raven N, Robinson C, Robson R, Sharp RJ.

Extremophiles. 2000 Oct;4(5):305-13.

PMID:
11057916
35.

Physiology and continuous culture of the hyperthermophilic deep-sea vent archaeon Pyrococcus abyssi ST549.

Godfroy A, Raven ND, Sharp RJ.

FEMS Microbiol Lett. 2000 May 1;186(1):127-32.

36.

Production of carcinoembryonic antigen (CEA) N-A3 domain in Pichia pastoris by fermentation.

Hellwig S, Robin F, Drossard J, Raven NP, Vaquero-Martin C, Shively JE, Fischer R.

Biotechnol Appl Biochem. 1999 Dec;30 ( Pt 3):267-75.

PMID:
10574697
37.

Thermostable archaeal O6-alkylguanine-DNA alkyltransferases.

Skorvaga M, Raven ND, Margison GP.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6711-5.

38.
39.

Tsp45I, a new thermostable site-specific endonuclease that cleaves the recognition sequence 5'-decreases GTSAC-3'.

Raven ND, Williams RA, Smith KE, Kelly CD, Carter ND.

Nucleic Acids Res. 1993 Sep 11;21(18):4397. No abstract available.

40.

A new restriction endonuclease, TspEI, from the genus Thermus that generates cohesive termini compatible with those of EcoRI.

Raven ND, Kelly CD, Carter ND, Eastlake P, Brown C, Williams RA.

Gene. 1993 Sep 6;131(1):83-6.

PMID:
8370544

Supplemental Content

Support Center